EXEL - Company ID 0000939767
The table below shows EXELIXIS, INC.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $610.81M | $597.75M | $568.26M | $555.45M | $539.54M | $637.18M |
| Cost of revenue | $19.95M | $18.57M | $19.47M | $19.17M | $17.33M | $17.67M |
| Gross profit | - | - | - | - | - | - |
| R&D | $199.92M | $199.16M | $200.36M | $212.23M | $222.57M | $211.15M |
EXELIXIS, INC. reported annual revenue of $2.32B for fiscal year 2026. That is up 7.0% from $2.17B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $191.45M (FY 2016) to $2.32B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $139.60M | $123.66M | $134.86M | $137.18M | $111.80M | $132.01M |
| Operating income | $251.34M | $236.54M | $213.58M | $186.86M | $136.07M | $275.87M |
| Income tax | $57.22M | $58.84M | $45.57M | $46.07M | $36.78M | $66.73M |
| Net income | $210.47M | $193.58M | $184.85M | $159.62M | $117.97M | $226.12M |
| EPS (diluted) | $0.79 | $0.69 | $0.65 | $0.55 | $0.40 | $0.77 |